Shares of Usana Health Sciences (USNA), a leading manufacturer of nutritional products and supplements, surged 6.12% on Tuesday, October 23, 2024, following an impressive third-quarter earnings report released the previous day.
Despite missing revenue expectations, Usana posted better-than-anticipated earnings per share for the quarter ended September 30, 2024. The company reported adjusted EPS of $0.56, surpassing Wall Street's consensus estimate of $0.49 and marking a slight improvement over the same period last year.
While Usana's revenue declined 6.2% year-over-year to $200.22 million, falling short of analysts' projections of $205.77 million, the company's strong earnings performance appeared to outweigh concerns over the top-line miss. Investors responded positively to the earnings beat, driving Usana's stock price higher.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。